Antibiotic Tumescent For Chronic Wounds
NCT06327113
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Non-healing Wound
Interventions
DRUG:
CeFAZolin Injectable Solution
Sponsor
University of California, Los Angeles